Please login to the form below
Gilead and Aelix join forces to pursue HIV ‘cure’
The HTI vaccine could replace antiretroviral therapy if it reaches market
Roche preps new Kadcyla filings after phase 3 trial win
Says the drug significantly reduced IDFS in women with residual disease
BMS finds a new immunotherapy partner with $12m Compugen deal
Combination with novel antibody targeting PVRIG pathway
A look ahead to key trial readouts at ESMO
New combinations and novel mechanisms on show
RET rivals Loxo and Blueprint face off with early-stage data
No clear winner between RET inhibitor rivals
Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit
Proposals come as EU plans major upgrade in trials regulation
Encouraging data for Roche flu drug ahead of FDA decision
Trial looks at benefts in high risk groups
Roche drug hits the mark in spinal muscular atrophy studies
Data suggests Risdiplam could improve motor function
Novo Nordisk to launch connected insulin pens
Also partners with Dexcom, Glooko and Roche on digital platforms
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
China’s Innovent to start US trials of anti-CD47 cancer drugSintilimab will be initially positioned for the Chinese market
-
Geron poleaxed as partner J&J abandons only pipeline drugShares drop by two-thirds as questions raised on imetelstat’s potential
-
Alexion adds to pipeline with $1.2bn Syntimmune buyAs company prepares for possible loss of patent protection for Soliris
-
Theranexus takes Alzheimer’s drug combo into clinic150-subject phase 1b trial to start at eight centres in France
-
Call for genetic tests to bring personalised medicine to children with cancerAction needed as childhood cancer survival has plateaued
-
Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3Contender could offer potency without dose-limiting toxicities
-
Novartis cuts manufacturing jobs in Switzerland and UKCuts include closure of Grimsby site by 2020
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
-
Dr Fiona Marshall heads up MSD's new UK research facility She will be based in London and focus on early bioscience discovery
Latest research appointments
Featured jobs
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director - Digital
-
Great salary and benefits
-
Associate Medical Director
-
Highly Competitive
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Advertising
-
Salary TBC
- Experienced Editor, London, Medical Communications
-
Competitive package
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Scientific Team Lead
-
Competitive Salary
-
Associate Medical Director
-
Salary TBC
- Director Healthcare PR Communications
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
Subscribe to our email news alerts
- Hancock's 'Tech Revolution' for NHS to be limited by budgets
- Merck & Co picks Nike exec to be digital transformation leader
- Gilead and Aelix join forces to pursue HIV ‘cure’
- Roche preps new Kadcyla filings after phase 3 trial win
- Novartis buys cancer specialist Endocyte for $2.1bn
- Porterhouse Medical rewards superb client service skills
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
Quick links
Infographics
